InspireMD Reports Q4 2025 Earnings with Revenue Growth and Net Loss
InspireMD (NSPR) reported Q4 2025 earnings with total revenue of $3.1 million, a 62% increase driven by the U.S. launch of CGuard Prime and international expansion. Despite revenue growth, the company recorded a net loss of $11.8 million, or $0.14 per share, reflecting increased operating expenses tied to commercial and marketing efforts.
Tickers: $NSPR
Topics: CGuard Prime earnings report financial performance international expansion revenue growth